Researchers compare the trends in cardiovascular disease-related mortality among patients with Alzheimer’s disease with general United States population.
Oleclumab by AstraZeneca for Prostate Cancer: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug